WallStreetZenWallStreetZen

NASDAQ: ZVRA
Zevra Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ZVRA

Based on 1 analyst offering 12 month price targets for Zevra Therapeutics Inc.
Min Forecast
$15.00+231.86%
Avg Forecast
$15.00+231.86%
Max Forecast
$15.00+231.86%

Should I buy or sell ZVRA stock?

Based on 1 analyst offering ratings for Zevra Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ZVRA stock forecasts and price targets.

ZVRA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-03

1 of 1

Forecast return on equity

Is ZVRA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is ZVRA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ZVRA revenue forecast

What is ZVRA's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$28.7M+4.52%
Avg 2 year Forecast
$108.5M+295.01%
Avg 3 year Forecast
$198.1M+621.28%
ZVRA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ZVRA revenue growth forecast

How is ZVRA forecast to perform vs Biotechnology companies and vs the US market?
Company
92.47%
Industry
37.04%
Market
9.92%
ZVRA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ZVRA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ZVRA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ZVRA$4.52$15.00+231.86%Buy
INMB$10.84N/AN/A
ADVM$9.39$33.33+254.98%Strong Buy
PSTX$2.05$15.00+631.71%Strong Buy
IPHA$2.40$11.50+379.17%Buy
View Top Biotech Stocks

Zevra Therapeutics Stock Forecast FAQ

Is Zevra Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ZVRA) stock is to Buy ZVRA stock.

Out of 1 analyst, 0 (0%) are recommending ZVRA as a Strong Buy, 1 (100%) are recommending ZVRA as a Buy, 0 (0%) are recommending ZVRA as a Hold, 0 (0%) are recommending ZVRA as a Sell, and 0 (0%) are recommending ZVRA as a Strong Sell.

If you're new to stock investing, here's how to buy Zevra Therapeutics stock.

What is ZVRA's revenue growth forecast for 2024-2026?

(NASDAQ: ZVRA) Zevra Therapeutics's forecast annual revenue growth rate of 92.47% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Zevra Therapeutics's revenue in 2024 is $27,461,000.On average, 3 Wall Street analysts forecast ZVRA's revenue for 2024 to be $1,246,461,817, with the lowest ZVRA revenue forecast at $985,774,422, and the highest ZVRA revenue forecast at $1,638,035,736. On average, 3 Wall Street analysts forecast ZVRA's revenue for 2025 to be $4,710,568,674, with the lowest ZVRA revenue forecast at $3,699,911,047, and the highest ZVRA revenue forecast at $6,136,554,344.

In 2026, ZVRA is forecast to generate $8,601,424,661 in revenue, with the lowest revenue forecast at $7,229,591,445 and the highest revenue forecast at $9,973,257,877.

What is ZVRA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ZVRA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ZVRA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ZVRA price target, the average ZVRA price target is $15.00, with the highest ZVRA stock price forecast at $15.00 and the lowest ZVRA stock price forecast at $15.00.

The Wall Street analyst predicted that Zevra Therapeutics's share price could reach $15.00 by Apr 3, 2025. The average Zevra Therapeutics stock price prediction forecasts a potential upside of 231.86% from the current ZVRA share price of $4.52.

What is ZVRA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ZVRA) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.